Development of early diaogostic kit for prostate cancer

Status

Active, not recruiting

Phases

Phase 4

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR-DNRC-08000178

Enrollment

Unknown

Registered

2008-11-03

Start date

2007-10-15

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

prostate Cancer

Interventions

Gold Standard:

Index test:

Eligibility

Sex/Gender

Male

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients with prostate cancer without chemotherapy or radiotherapy, patients with benign prostate hyperplasia or prostatitis,health man

Exclusion criteria

Exclusion criteria: Patients with prostate cancer after chemotherapy or radiotherapy

Design outcomes

Primary

Measure	Time frame
leveles of serum EECP;	—

Secondary

Measure	Time frame
protein expression leveles of cancer tissue and EECP;	—

Countries

China

Contacts

Public ContactHong Zheng

huyongwyp@vip.sina.com+86 028 81812830

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026